AbbVie (ABBV) Raw Materials (2012 - 2016)

AbbVie (ABBV) has 5 years of Raw Materials data on file, last reported at $132.0 million in Q2 2016.

• Raw Materials for Q2 2016 came in at $132.0 million, up 4.76% year-over-year; the trailing twelve-month figure through Jun 2016 was $132.0 million (up 4.76% YoY), and the FY2015 annual result was $169.0 million, up 9.74% from the prior year.
• Raw Materials retreated to $132.0 million in Q2 2016 per ABBV's latest filing, from $155.0 million in the prior quarter.
• Over five years, Raw Materials peaked at $261.0 million in Q4 2013 and troughed at $126.0 million in Q2 2015.
• A 5-year average of $188.2 million and a median of $163.0 million in 2015 frame the typical range for Raw Materials.
• On a YoY basis, Raw Materials climbed as much as 9.74% in 2015 and fell as far as 45.02% in 2015.
• A 5-year view of Raw Materials shows it stood at $258.0 million in 2012, then climbed by 1.16% to $261.0 million in 2013, then slumped by 41.0% to $154.0 million in 2014, then advanced by 9.74% to $169.0 million in 2015, then slipped by 21.89% to $132.0 million in 2016.
• Business Quant data shows ABBV's Raw Materials at $132.0 million in Q2 2016, $155.0 million in Q1 2016, and $169.0 million in Q4 2015.